Market Research Logo

Biotronik SE & Co. KG - Product Pipeline Analysis, 2016 Update

Summary

Biotronik SE & Co. KG (Biotronik) develops, manufactures and distributes cardio and endovascular medical devices. The company offers cardiac rhythm therapy solutions, electrophysiology products and vascular intervention products. Its technologies include Home Monitoring, ProMRI, DX Atrial Sensing, Closed Loop Stimulation, AlCath Flux eXtra Gold and others. Biotronik’ products are used in various areas including bradycardia therapy, tachyarrhythmia therapy, electrophysiology, cardiac resynchronization, Coronary vascular intervention, peripheral vascular intervention. It has manufacturing facilities in Germany, Switzerland and the US. The company markets its products through a network of sales force across Europe, North America, Latin America, Asia, Oceania and Africa. Biotronik is headquartered in Berlin, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biotronik SE & Co. KG
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Biotronik SE & Co. KG Company Snapshot
Biotronik SE & Co. KG Company Overview
Key Information
Biotronik SE & Co. KG Pipeline Products and Clinical Trials Overview
Biotronik SE & Co. KG – Pipeline Analysis Overview
Business Description
Biotronik SE & Co. KG - Major Products and Services
Biotronik SE & Co. KG Pipeline Products by Development Stage
Biotronik SE & Co. KG Clinical Trials by Trial Status
Biotronik SE & Co. KG Pipeline Products Overview
AMS-1
AMS-1 Product Overview
AMS-2
AMS-2 Product Overview
Astron Peripheral Vascular Stent
Astron Peripheral Vascular Stent Product Overview
Astron Peripheral Vascular Stent Clinical Trial
Astron Pulsar Self Expanding Peripheral Stent
Astron Pulsar Self Expanding Peripheral Stent Product Overview
Astron Pulsar Self Expanding Peripheral Stent Clinical Trial
DREAMS
DREAMS Product Overview
DREAMS 2
DREAMS 2 Product Overview
DREAMS 2 Clinical Trial
Orsiro Hybrid Drug Eluting Stent
Orsiro Hybrid Drug Eluting Stent Product Overview
Orsiro Hybrid Drug Eluting Stent Clinical Trial
ProGenic Pimecrolimus-eluting Coronary Stent System
ProGenic Pimecrolimus-eluting Coronary Stent System Product Overview
ProMRI Iforia 5 HF-T ICD
ProMRI Iforia 5 HF-T ICD Product Overview
ProMRI Iforia 5 Series DR-T ICD
ProMRI Iforia 5 Series DR-T ICD Product Overview
ProMRI Iforia 5 Series DR-T ICD Clinical Trial
ProMRI Iforia 5 VR-T DX ICD
ProMRI Iforia 5 VR-T DX ICD Product Overview
ProMRI Iforia 5 VR-T ICD
ProMRI Iforia 5 VR-T ICD Product Overview
ProMRI Iforia 7 DR-T ICD
ProMRI Iforia 7 DR-T ICD Product Overview
ProMRI Iforia 7 HF-T ICD
ProMRI Iforia 7 HF-T ICD Product Overview
ProMRI Iforia 7 VR-T DX ICD
ProMRI Iforia 7 VR-T DX ICD Product Overview
ProMRI Iforia 7 VR-T ICD
ProMRI Iforia 7 VR-T ICD Product Overview
Pulsar-18 Self Expanding Stent
Pulsar-18 Self Expanding Stent Product Overview
Biotronik SE & Co. KG - Key Competitors
Biotronik SE & Co. KG - Key Employees
Biotronik SE & Co. KG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Biotronik SE & Co. KG, Recent Developments
Feb 01, 2016: BIOTRONIK Announces CE Approval for new series of ICDs and CRT-Ds with MRI AutoDetect
Jan 26, 2016: BIOTRONIK Announces Expansion Of Passeo-18 Lux Drug-Coated Balloon Portfolio
Dec 22, 2015: FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology
Dec 22, 2015: FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology
Dec 10, 2015: BIOTRONIK Announces Start of New Study Evaluating whether Pacemakers with Closed Loop Stimulation Prevent Reflex Syncope
Dec 04, 2015: BIOTRONIK and Cardiology Experts Support Heartbeat International in Top Education
Dec 02, 2015: BIOTRONIK and Heartbeat International Foundation Conclude Milestone Year by Opening Heart Center in the Dominican Republic
Dec 01, 2015: BIOTRONIK Announces Start of Study to Evaluate Benefits of Unique Rate Response Algorithm for Atrial Fibrillation Patients
Dec 01, 2015: World’s Only Company to Offer Japan’s ICD and Pacemaker Patients 3 Tesla MRI Access
Nov 20, 2015: BIOTRONIK Announces Improved Patient Outcomes with Innovative “Combination Therapy” for Peripheral Artery Disease
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Biotronik SE & Co. KG, Key Facts
Biotronik SE & Co. KG Pipeline Products and Clinical Trials Overview
Biotronik SE & Co. KG Pipeline Products by Equipment Type
Biotronik SE & Co. KG Pipeline Products by Indication
Biotronik SE & Co. KG Clinical Trials by Trial Status
Biotronik SE & Co. KG, Major Products and Services
Biotronik SE & Co. KG Number of Pipeline Products by Development Stage
Biotronik SE & Co. KG Pipeline Products Summary by Development Stage
Biotronik SE & Co. KG Clinical Trials by Trial Status
Biotronik SE & Co. KG Clinical Trials Summary
AMS-1 - Product Status
AMS-1 - Product Description
AMS-2 - Product Status
AMS-2 - Product Description
Astron Peripheral Vascular Stent - Product Status
Astron Peripheral Vascular Stent - Product Description
Astron Peripheral Vascular Stent - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents
Astron Pulsar Self Expanding Peripheral Stent - Product Status
Astron Pulsar Self Expanding Peripheral Stent - Product Description
Astron Pulsar Self Expanding Peripheral Stent - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents
Astron Pulsar Self Expanding Peripheral Stent - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar-18 Stents (BIOFLEX-I Europe)
DREAMS - Product Status
DREAMS - Product Description
DREAMS 2 - Product Status
DREAMS 2 - Product Description
DREAMS 2 - BIOTRONIK - Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold (DREAMS 2nd Generation) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries: BIOSOLVE-II
Orsiro Hybrid Drug Eluting Stent - Product Status
Orsiro Hybrid Drug Eluting Stent - Product Description
Orsiro Hybrid Drug Eluting Stent - A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-eluting Stent with a Durable Polymer Everolimus-eluting Stent for Patients with Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Orsiro Hybrid Drug Eluting Stent - BIOFLOW-VI Clinical Study in China
Orsiro Hybrid Drug Eluting Stent - Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX): A Randomized Trial with Stent Evaluation in All-comers IV (TWENTE IV)
Orsiro Hybrid Drug Eluting Stent - BIOTRONIK - A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects with up to Three De Novo or Restenotic Coronary Artery Lesions - V
Orsiro Hybrid Drug Eluting Stent - BIOTRONIK - Safety and Performance Registry for an All-comers Patient Population with the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III French Satellite
Orsiro Hybrid Drug Eluting Stent - BIOTRONIK - Safety and Performance Registry for an All-comers Patient Population with the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III United Kingdom Satellite
Orsiro Hybrid Drug Eluting Stent - Harmonized Optimal Strategy to Treat Coronary Artery Disease - Coronary Intervention with Next Generation Drug-eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy Trial (HOST-IDEA)
Orsiro Hybrid Drug Eluting Stent - Randomized Comparison of a Polymer-free Biolimus-eluting BioFreedom Stent with a Biodegradable-polymer Sirolimus-eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention
Orsiro Hybrid Drug Eluting Stent - The Comparison of Strategies to PREPARE Severely CalCified Coronary Lesions Trial (PREPARE-CALC): A Prospective Randomized Controlled Trial of Rotational Atherectomy Versus Cutting/Scoring Balloon in Severely Calcified Coronary Lesions
ProGenic Pimecrolimus-eluting Coronary Stent System - Product Status
ProGenic Pimecrolimus-eluting Coronary Stent System - Product Description
ProMRI Iforia 5 HF-T ICD - Product Status
ProMRI Iforia 5 HF-T ICD - Product Description
ProMRI Iforia 5 Series DR-T ICD - Product Status
ProMRI Iforia 5 Series DR-T ICD - Product Description
ProMRI Iforia 5 Series DR-T ICD - ProMRI 3T ENHANCED Master Study
ProMRI Iforia 5 VR-T DX ICD - Product Status
ProMRI Iforia 5 VR-T DX ICD - Product Description
ProMRI Iforia 5 VR-T ICD - Product Status
ProMRI Iforia 5 VR-T ICD - Product Description
ProMRI Iforia 7 DR-T ICD - Product Status
ProMRI Iforia 7 DR-T ICD - Product Description
ProMRI Iforia 7 HF-T ICD - Product Status
ProMRI Iforia 7 HF-T ICD - Product Description
ProMRI Iforia 7 VR-T DX ICD - Product Status
ProMRI Iforia 7 VR-T DX ICD - Product Description
ProMRI Iforia 7 VR-T ICD - Product Status
ProMRI Iforia 7 VR-T ICD - Product Description
Pulsar-18 Self Expanding Stent - Product Status
Pulsar-18 Self Expanding Stent - Product Description
Biotronik SE & Co. KG, Key Employees
Biotronik SE & Co. KG, Subsidiaries
List of Figures
Biotronik SE & Co. KG Pipeline Products by Equipment Type
Biotronik SE & Co. KG Pipeline Products by Development Stage
Biotronik SE & Co. KG Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report